Significant publications on infectious diseases pharmacotherapy in 2014

Kady Phe, Richard M. Cadle, David J. Guervil, Oscar E. Guzman, Ashley M. Lockwood, Katherine K. Perez, Nancy N. Vuong, Samuel L. Aitken

Research output: Contribution to journalArticlepeer-review

8 Scopus citations


Purpose. The most important articles on infectious diseases (ID) pharmacotherapy published in the peer-reviewed literature in 2014, as nominated and selected by panels of pharmacists and others with ID expertise, are summarized. Summary. Members of the Houston Infectious Diseases Network were asked to nominate articles published in 2014 from prominent peer-reviewed journals that were felt to have a major impact in the field of ID pharmacotherapy. A list of 19 nominated articles on general ID- related topics and 9 articles specifically related to human immunodeficiency virus (HIV) infection or acquired immunodeficiency syndrome (AIDS) was compiled. In a national online survey, members of the Society of Infectious Diseases Pharmacists (SIDP) were asked to select from the list 10 general ID articles believed to have made a significant contribution to the field of ID pharmacotherapy and 1 article contributing to HIV/AIDS pharmacotherapy. Of the 291 SIDP members surveyed, 134 (46%) and 56 (19%) participated in the selection of general ID-related articles and HIV/ AIDS-related articles, respectively. The 11 highest-ranked papers (10 general ID- related articles, 1 HIV/AIDS-related article) are summarized here. Conclusion. With the vast number of articles published each year, it is difficult to remain up-to-date on current, significant ID pharmacotherapy publications. This review of significant publications in 2014 may be helpful by lessening this burden.

Original languageEnglish (US)
Pages (from-to)1380-1392
Number of pages13
JournalAmerican Journal of Health-System Pharmacy
Issue number16
StatePublished - Aug 15 2015

ASJC Scopus subject areas

  • Pharmacology
  • Health Policy


Dive into the research topics of 'Significant publications on infectious diseases pharmacotherapy in 2014'. Together they form a unique fingerprint.

Cite this